Denali Therapeutics Inc.

DNLI

Sector
NA

Industry
NA

Website




Buy / Sell (dollars)

1 Month

0% 0% Complete (success)
100% 100% Complete (danger)
$0.00
avg. $0.00
$22.737M
avg. $22.737M

Buy/Sell Ratio

0

Transactions

14

Filers

10

3 Month

0% 0% Complete (success)
100% 100% Complete (danger)
$0.00
avg. $0.00
$22.737M
avg. $7.579M

Buy/Sell Ratio

0

Transactions

14

Filers

10

12 Month

0% 0% Complete (success)
100% 100% Complete (danger)
$3,320.08
avg. $276.67
$25.182M
avg. $2.099M

Buy/Sell Ratio

0

Transactions

53

Filers

14

24 Month

1.3% 1.3% Complete (success)
98.7% 98.7% Complete (danger)
$476,169.04
avg. $19,840.38
$34.904M
avg. $1.454M

Buy/Sell Ratio

0.014

Transactions

169

Filers

14

Recent Filings - SEC Form 4


CFO Buys & Sells

The following shows events open market buys and sells made by CFOs. The CFO is likely to be the best person within a company to watch for insider signals.
On the right you can see the maximum upside and downside produced in the 7 months after the filing was made and how long it took to arrive.
These values are updated daily.

CFO data is restricted to data over 5 years old.
You need a free account to see up-to-date data.
Log in to get free access to this feature and more.

No open market CFO buys or sells found.



Filers